A Long-Acting Biologic with Transmucosal Transport Properties That Arrest SARS-CoV-2 Virus Variants

ReachMD Healthcare Image


A Long-Acting Biologic with Transmucosal Transport Properties to Arrest SARS-CoV-2 Virus Variants

A Long-Acting Biologic with Transmucosal Transport Properties to Arrest SARS-CoV-2 Virus Variants

The ongoing COVID-19 pandemic caused by the SARS-CoV-2 virus has highlighted the urgent need for effective treatments. As the virus continues to evolve and produce new variants, it becomes crucial to develop innovative therapeutic approaches that can combat these emerging strains. One promising solution is the development of a long-acting biologic with transmucosal transport properties.

Understanding the Transmucosal Transport Properties

Transmucosal transport refers to the ability of a substance to cross the mucosal barriers in the body, such as those found in the respiratory, gastrointestinal, and genitourinary tracts. This property allows for direct delivery of therapeutics to the site of infection, bypassing the need for systemic circulation.

In the case of SARS-CoV-2, the virus primarily enters the body through the respiratory tract. By developing a biologic with transmucosal transport properties, it becomes possible to deliver the therapeutic directly to the respiratory mucosa, where the virus replicates and causes damage.

The Benefits of a Long-Acting Biologic

A long-acting biologic refers to a therapeutic agent that has an extended duration of action, requiring fewer administrations compared to traditional treatments. This characteristic is particularly advantageous in the context of a rapidly evolving virus like SARS-CoV-2.

By utilizing a long-acting biologic with transmucosal transport properties, it becomes possible to achieve sustained release of the therapeutic agent at the site of infection. This continuous exposure to the therapeutic can help prevent viral replication, reduce the severity of symptoms, and potentially halt the emergence of new variants.

The Potential of Arresting SARS-CoV-2 Virus Variants

The ability to arrest SARS-CoV-2 virus variants is a critical goal in the fight against the COVID-19 pandemic. By targeting the respiratory mucosa directly with a long-acting biologic, it becomes possible to inhibit viral replication and prevent the emergence of new variants.

Furthermore, the transmucosal transport properties of the biologic can enhance its efficacy by ensuring efficient delivery to the site of infection. This targeted approach minimizes systemic exposure and potential side effects, while maximizing the therapeutic impact.


The development of a long-acting biologic with transmucosal transport properties represents a promising approach to combat the evolving SARS-CoV-2 virus variants. By directly targeting the respiratory mucosa, this innovative therapeutic strategy can potentially arrest viral replication, reduce symptoms, and prevent the emergence of new variants.

As research and development in this field continue, it is hoped that such a biologic will contribute significantly to the global efforts in controlling the COVID-19 pandemic and ensuring a healthier future for all.

© Article Copyright 1999-2023

Life Technology™


If you would like to republish the content of this or any other article from www.lifetechnology.com for commercial purposes visit

Life Technology™ News Content Syndication Licence

. If you would like to republish the content of this or any other article from www.lifetechnology.com for non commercial purposes visit

Copyright And Royalty Free RSS Feeds For Commercial And Non Commercial Use


If you would like for us to publish your article at www.lifetechnology.com visit

Publish Your Article At Life Technology™

. If you would like to advertise here and on all 100,000+ pages of www.lifetechnology.com visit

Advertise At Life Technology™

. For corporate sponsorship of www.lifetechnology.com visit

Corporate Sponsorship


Since 1999 Life Technology™ has published medical science and technology news content totally free of charge. Because we do not charge a subscription fee we would kindly request that you

Make A Donation To Life Technology™

and please, do share this article with your coworkers, friends, family and favorite social media platform.

  • New research compares five retinoids for anti-photoaging therapy
  • Artificial intelligence used in new COVID-19 test improves accuracy
  • Understanding rapid tendon regeneration in newts may one day help human athletes
  • A long-acting biologic with transmucosal transport properties that arrest SARS-CoV-2 virus variants
  • Aussie babies and toddlers are targeted with unhealthy foods, finds research
  • Investigating how genetic and environmental factors influence the risk and course of eating disorders
  • With some forms of traumatic brain injury, non-deployed vets have higher risk of epilepsy than deployed
  • DNA sequencing reveals clonal evolution of tumor in childhood leukemia
  • Certain migraine medications may be more effective than ibuprofen
  • Researchers identify cell signaling pathways controlling melanoma cell metastasis to the brain
  • How your weight changes over time can impact your health
  • Breaking down barriers: What happens when the vaginal microbiome attacks
  • Why you should talk about fertility, even if you don't want children. And what you should discuss
  • Do you really need antibiotics? Curbing our use can help fight drug-resistant bacteria
  • 'I can see the characters': How reading aloud to patients can break through 'cancer fog'
  • Researchers: Lifestyle changes can reduce dementia risk by maintaining brain plasticity, but the time to act is now
  • Meal kits are booming, but how do they stack up nutritionally?
  • Report: Nazi doctors weren't just 'a few bad apples.' Simplistic stories won't help guard against future medical abuses
  • Exploring the role of marketing in disrupted health care markets
  • A smart glove to improve stroke rehabilitation
  • Clinicians, practices and patients all have a part to play in dealing with risks of remote GP consultations
  • Is assisted dying available equally to all in New Zealand?
  • Study: Cannabis use disorder increasing among veterans with psychiatric disorders
  • Conscientious personalities less at risk of dementia diagnosis, analysis suggests
  • Mental health costs of lockdown compliance still being felt, research shows
  • Genetic switches in tumor development may lead to new therapeutic target for colorectal cancer
  • Sit all day? Periodic squatting exercises may help preserve your brain power
  • Fighting fruit flies help researchers understand why we stay angry
  • Already-licensed drugs could be trialed to potentially treat secondary brain cancer, new research finds
  • Survey suggests lack of awareness of the effects of gym lifestyles in young male gym goers
  • How can health care systems research improve health equity?
  • Cost of maternity care in Queensland is rising while adverse birth outcomes have become more frequent
  • Age at menopause could determine risk for decline in muscle mass and strength
  • Research highlights need for education to combat cancer in Appalachia
  • Instead of calories and macros, think about the level of food processing, expert says
  • Exploring how OCD therapy retrains the brain
  • Mindfulness-based intervention shows promise for PTSD in cardiac arrest survivors
  • Mounjaro beats Ozempic for weight loss in early trial
  • Thyroid cancer prevalent among transgender female veterans
  • How can adults with congenital heart disease reduce risks? Study finds lifetime cardiology monitoring is key
  • New target identified for drugs to treat cancer and age-related diseases
  • Doctors call for expanded reporting of medical care given in Immigration and Customs Enforcement detention centers
  • Scientists unveil genetic programs controlling the development of cellular diversity in the cerebellum
  • Newborn babies at risk from bacteria commonly carried by mothers, finds study
  • Brain scans of former NFL athletes show a repair protein in place long after initial injury
  • Examining what smoking does to oral bacteria
  • New method uses platelets to predict risk of serious COVID-19 infection
  • New method can detect early-stage breast cancer in two minutes, study claims
  • Researchers find connections between neuroinflammation and Alzheimer's disease
  • Researchers study the link between the bacteria H. pylori and stomach cancer

  • Life Technology™ Medical NewsFeedburnerGoogleRSSLife Technology™ Science NewsFeedburnerGoogleRSSLife Technology™ Technology NewsFeedburnerGoogleRSS

    Facebook Comments



    We’re glad to see you’re enjoying Global Oncology Academy…
    but how about a more personalized experience?

    Register for free